resTORbio (TORC) Sets New 52-Week High and Low at $8.26

resTORbio (NASDAQ:TORC)’s share price hit a new 52-week high and low on Friday . The stock traded as low as $8.26 and last traded at $8.49, with a volume of 221185 shares trading hands. The stock had previously closed at $9.57.

Several brokerages have weighed in on TORC. Evercore ISI began coverage on resTORbio in a research note on Tuesday, February 20th. They set an “outperform” rating and a $28.00 price objective on the stock. Bank of America began coverage on resTORbio in a research note on Tuesday, February 20th. They set a “buy” rating and a $23.00 price objective on the stock. Leerink Swann began coverage on resTORbio in a research note on Tuesday, February 20th. They set an “outperform” rating and a $36.00 price objective on the stock. Finally, Wedbush began coverage on resTORbio in a research note on Tuesday, February 20th. They set an “outperform” rating and a $30.00 price objective on the stock.

How to Become a New Pot Stock Millionaire

The company has a market cap of $268.40 and a price-to-earnings ratio of -1.01.

resTORbio (NASDAQ:TORC) last issued its quarterly earnings data on Thursday, March 29th. The company reported ($5.11) earnings per share for the quarter, missing the consensus estimate of ($1.03) by ($4.08). sell-side analysts expect that resTORbio will post -1.82 earnings per share for the current fiscal year.

In other resTORbio news, Director Orbimed Advisors Llc bought 533,333 shares of the stock in a transaction dated Tuesday, January 30th. The shares were bought at an average cost of $15.00 per share, for a total transaction of $7,999,995.00. The purchase was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, major shareholder Puretech Health Llc bought 233,333 shares of the stock in a transaction dated Tuesday, January 30th. The shares were acquired at an average price of $15.00 per share, for a total transaction of $3,499,995.00. The disclosure for this purchase can be found here.

COPYRIGHT VIOLATION WARNING: “resTORbio (TORC) Sets New 52-Week High and Low at $8.26” was originally reported by Ticker Report and is the sole property of of Ticker Report. If you are reading this piece on another website, it was stolen and republished in violation of US & international trademark & copyright laws. The correct version of this piece can be accessed at https://www.tickerreport.com/banking-finance/3339946/restorbio-torc-sets-new-52-week-high-and-low-at-8-26.html.

resTORbio Company Profile

resTORbio, Inc, a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of aging-related diseases. Its lead program is targeting the selective inhibition of TORC1, an evolutionary conserved pathway that contributes to the decline in function of multiple organ systems, including the immune, cardiac, and neurologic systems.

Receive News & Ratings for resTORbio Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for resTORbio and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

LPL Financial LLC Purchases 4,212 Shares of Marvell Technology Group
LPL Financial LLC Purchases 4,212 Shares of Marvell Technology Group
LPL Financial LLC Has $434,000 Stake in Dreyfus Strategic Muni.
LPL Financial LLC Has $434,000 Stake in Dreyfus Strategic Muni.
LPL Financial LLC Acquires 1,208 Shares of Broadridge Financial Solutions
LPL Financial LLC Acquires 1,208 Shares of Broadridge Financial Solutions
1,253 Shares in McDonald's Co.  Acquired by Landmark Financial Advisors LLC
1,253 Shares in McDonald's Co. Acquired by Landmark Financial Advisors LLC
Sprott Junior Gold Miners ETF  Shares Bought by LPL Financial LLC
Sprott Junior Gold Miners ETF Shares Bought by LPL Financial LLC
Kanawha Capital Management LLC Sells 84,108 Shares of General Electric
Kanawha Capital Management LLC Sells 84,108 Shares of General Electric


Leave a Reply

© 2006-2018 Ticker Report. Google+.